Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
Centro de Biología Molecular Severo Ochoa (CBMSO), Consejo Superior de Investigaciones Científicas (CSIC)-Universidad Autónoma de Madrid (UAM), Madrid, Spain.
Nat Immunol. 2021 Jun;22(6):687-698. doi: 10.1038/s41590-021-00927-z. Epub 2021 May 13.
The aged adaptive immune system is characterized by progressive dysfunction as well as increased autoimmunity. This decline is responsible for elevated susceptibility to infection and cancer, as well as decreased vaccination efficacy. Recent evidence indicates that CD4 T cell-intrinsic alteratins contribute to chronic inflammation and are sufficient to accelerate an organism-wide aging phenotype, supporting the idea that T cell aging plays a major role in body-wide deterioration. In this Review, we propose ten molecular hallmarks to represent common denominators of T cell aging. These hallmarks are grouped into four primary hallmarks (thymic involution, mitochondrial dysfunction, genetic and epigenetic alterations, and loss of proteostasis) and four secondary hallmarks (reduction of the TCR repertoire, naive-memory imbalance, T cell senescence, and lack of effector plasticity), and together they explain the manifestation of the two integrative hallmarks (immunodeficiency and inflammaging). A major challenge now is weighing the relative impact of these hallmarks on T cell aging and understanding their interconnections, with the final goal of defining molecular targets for interventions in the aging process.
衰老的适应性免疫系统的特点是功能逐渐失调以及自身免疫增加。这种衰退导致易感染和癌症,以及疫苗效果降低。最近的证据表明,CD4 T 细胞内在的改变导致慢性炎症,并足以加速全身衰老表型,支持 T 细胞衰老在全身恶化中起主要作用的观点。在这篇综述中,我们提出了十个分子特征来代表 T 细胞衰老的共同特征。这些特征分为四个主要特征(胸腺萎缩、线粒体功能障碍、遗传和表观遗传改变以及蛋白质平衡丧失)和四个次要特征(TCR 库减少、幼稚记忆失衡、T 细胞衰老和缺乏效应器可塑性),它们共同解释了两个综合特征(免疫缺陷和炎症老化)的表现。现在的一个主要挑战是权衡这些特征对 T 细胞衰老的相对影响,并了解它们的相互联系,最终目标是确定干预衰老过程的分子靶点。
Nat Immunol. 2021-6
Indian J Med Res. 2013-11
Cell. 2013-6-6
Clin Immunol. 2018-4-11
Exp Gerontol. 2014-6
Front Biosci. 1999-3-1
J Mol Med (Berl). 2023-11
Exp Mol Med. 2025-9-1
Vet Sci. 2025-7-24
Nat Rev Cancer. 2025-8-14
Nat Aging. 2025-8
Nat Immunol. 2021-2
Cell Rep. 2020-12-15
Front Immunol. 2020